Larimar Therapeutics, Inc. Common Stock (LRMR) is a publicly traded Healthcare sector company. As of May 21, 2026, LRMR trades at $3.53 with a market cap of $336.58M and a P/E ratio of 0.00. LRMR moved +5.71% today. Year to date, LRMR is +5.06%; over the trailing twelve months it is +71.36%. Its 52-week range spans $1.61 to $9.50. Analyst consensus is strong buy with an average price target of $16.00. Rallies surfaces LRMR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Larimar Therapeutics, Inc. Common Stock (LRMR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LRMR moved +5.71% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $3.53 |
| Market Cap | $336.58M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.50 |
| 52-Week Low | $1.61 |
| Volume | 1.74M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-165.67M |
| Gross Margin | 0.00% |
5 analysts cover LRMR: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.00.